Nytt nummer av SU:s nyhetsbrev. Med forskning om #hedersvåld 20 år efter mordet på Fadime Sahindal, rymdteleskopet James Webb #JWST, om #diabetes, att farlig #PFAS slungas upp på land från havet, en ny supernova, #entreprenörskap mm Läs o prenumerera: su.se/om-universitet…

For the next three weeks, we will take you through the mitochondria to show you how it works. Let's start by zooming in to this awesome organelle. #3D #biology #mitochondria #ATP #animations

Evolution of pinniped UCP1 is not linked to aquatic life but to neonatal thermogenesis and body size pnas.org/content/119/6/…

Idag är det #WomenInScienceDay Lyssna till ett nytt avsnitt av podden Insights to Science där 5 kvinnliga forskare vid Stockholms universitet intervjuas av @cloudcyclist om hur de blev forskare och ger råd till unga forskare. #WomenInScience #scicomm #forskkom open.spotify.com/episode/3V19Zj…

A timely reminder by my fabulous colleague Yongguo Li and myself: "Uncoupling Protein 1 Does Not Produce Heat without Activation" - buff.ly/3IeqO9y

Read here Tore Bengtsson work on measuring heat production $brtx #heat #brownadipose #metabolism nature.com/articles/s4200…

▪️Ketogenic diet has been the top diet over the last 5 years ▪️Obesity has risen to unprecedented heights over the last 5 years 🤔 ⁦Dr. Spencer Nadolsky⁩ ⁦John Speakman⁩

#Exercise is good for everyone, but not everyone responds the same🚴‍♀️. People with type 2 #diabetes have enhanced #inflammation in skeletal #muscle after acute exercise. Check our publication in Science Advances! science.org/doi/10.1126/sc… Image credits: @Csilph

Hi #AcademicTwitter ! I have a fully funded PhD position available in the Department of Molecular Biosciences at Stockholm University. 🧪🥼🔍 Read more 👇 su.se/english/about-… Application deadline: 07/01/2023 #physiology #sciencetwitter #PhDposition

Individuals with class 3 obesity (BMI > 40) have up to 17 years of lower life expectancy. Compare this to smokers who have 8.9 years of lower life expectancy to non-smokers. #ADA2024 #ADASciSessions

Presented at #ADASciSessions: In the REDEFINE 1 phase 3a trial, semaglutide at a dose of 2.4 mg with cagrilintide at a dose of 2.4 mg led to significant body-weight reduction in adults without diabetes and with overweight or obesity. Full trial results: nej.md/444aW7f

This is a great snapshot of the current non-peptide #GLP1R agonist pipeline. The development of a convenient oral pill could be a game changer for treating #T2D and #obesity

Here GRK-biased β2AR partial agonists are identified as promising oral alternatives to injectable incretin mimetics used in the treatment of type 2 #diabetes and #obesity Cell cell.com/cell/fulltext/…

Some journeys are long. This one took 15 years! Our new Cell paper details a new class of GRK-biased agonists that reshape body composition by reducing fat while sparing muscle, offering a solution to the #GLP1 challenge. With a strong safety profile confirmed in our

Biased adrenergic agonists – a novel treatment for diabetes! Amazing paper in Cell from a project led by Tore Bengtsson (Stockholm Uni) and Shane Wright (Karolinska Inst): cell.com/cell/fulltext/… Great work by my student Nour Kahlous, who performed simulations of the compounds.

Skeletal muscle proteomics: considerations and opportunities nature.com/articles/s4432…

Our recent work was highlighted in Nature Reviews Drug Discovery ! Read more at: nature.com/articles/d4157…